• Home
  • NEW DAY MEDICINE
  • 12(50)2022
  • 25 -12 (50) 2022 — Tairova M.I., Khayitboeva M.R. — POSSIBILITIES OF MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF OVARIAN CANCER

25 -12 (50) 2022 — Tairova M.I., Khayitboeva M.R. — POSSIBILITIES OF MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF OVARIAN CANCER

POSSIBILITIES OF MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF OVARIAN CANCER

Tairova M.I., Tashkent Medical Academy

Khayitboeva M.R., Tashkent Medical Academy

Ismailova M.Kh., Tashkent Medical Academy

Xaqberdiyev J.Ch. Tashkent Medical Academy

Resume

In the last decade, the demand for magnetic resonance imaging has increased markedly as a diagnostic method, as it has unprecedented potencial to create tissue contrast based on differences in tissue properties. Information about tissue structure and function can also be obtained using sonography. In addition, MSCT studies can be used in the diagnosis of ovarian canser, but  only in the later stages of its development.

Key words: magnetic resonance imaging, ovarian cancer, staging, DWI.

First page

150

Last page

156

For citation: Tairova M.I., Khayitboeva M.R., Ismailova M.Kh., Xaqberdiyev J.Ch. POSSIBILITIES OF MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF OVARIAN CANCER //New Day in Medicine 12(50)2022 150-156 https://clck.ru/337AQJ

LIST OF REFERENCES:

  1. Никогосян С.О., Кузнецов В.В. Рак яичников: вопросы диагностики и современные методы лечения. Врач. 2010; 9 (2): 2–8.
  2. Состояние онкологической помощи населению России в 2014 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой.М.: РИИС ФИАН, 2015. Доступно по: http://www.oncology.ru/service/statistics/condition/2014.pdf
  3. Khattak Y.J., Hafeez S., Alam T., Beg M., Awais M., Masroor I. Ovarian masses: Is multi-detector computed tomography a reliable imaging modality? Asian Pac J Cancer Prev. 2013; 14 (4): 2627–2630.
  4. Суконко О.Г., Моисеев П.И., Океанов А.Е. Специализированная медицинская помощь онкологическим пациентам в 2013 г. Онкологический журнал. 2014; 1 (29): 5–16.
  5. Pickhardt P.J., Hanson M.E. Incidental adnexal masses detected at low-dose unenhanced CT in asymptomatic women age 50 and older: Implications for clinical management and ovarian cancer screening. Radiology. 2010; 257 (1): 144–150. DOI:10.1148/radiol.10100511
  6. Барчук А.С., Мерабишвили В.М. Выживаемость онкологических больных. СПб., 2006.
  7. Злокачественные новообразования в России в 2010 году. Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: РИИС ФИАН; 2012. Доступно по http://www.oncology.ru/service/statistics/malignant_tumors/2010.pdf
  8. Состояние онкологической помощи населению России в 2015 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой М.: РИИС ФИАН; 2016.
  9. Chan J.K., Tian C., Monk B.J. Prognostic factors for high-risk early stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer. 2008; 112 (10): 2202–2210. DOI: 10.1002/cncr.23390
  10. Paulsen T., Kaern J., Trope C. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery. GynecOncol. 2011; 122 (1): 83–88. DOI: 10.1016/j.ygyno.2011.02.038
  11. Foley O.W., J. Rauh-Hain A., Del Carmen M.G. Recurrent epithelial ovarian cancer: an update on treatment. Oncology. 2013; 27 (4): 288–294. http://www.cancernetwork.com/oncology-journal/recurrent-epithelial-ovarian-cancer-update-treatment
  12. Берген Т.А., Трофименко И.А. Методика МР-диффузии и ее применение в исследовании опухолей малого таза у женщин. Бюллетень сибирской медицины. 2012; 11 (1): 10–12.
  13. Chilla B., Hauser N., Singer G., Trippel M., Froehlich J.M., Kubik-Huch R.A. Indeterminate adnexal masses at ultrasound: effect of MRI imaging findings on diagnostic thinking and therapeutic decisions. Eur Radiol. 2011; 21 (6): 1301–1310. DOI: 10.1007/s00330–010–2018-x
  14. Foti P.V., Attina G., Spadola S., Caltabiano R., Farina R., Palmucci S. et al. MR-imaging of ovarian masses: classification and differential diagnosis. Insights Imaging.2016; 7 (1): 21–41. DOI: 10.1007/s13244–015–0455–4
  15. Cui Y.F., Li W.H., Zhu M.J. et al. Clinical application and research of diffusion weighted MR imaging in complex ovarian tumors. //Journal of China Clinic Medical Imaging.2012; 23: 856–859.
  16. Долгушин Б.И., Тюрин И.Е., Лукьянченко А.Б., Медведева Б.М., Дронова Е.Л., Шима В., и др. Стандарты проведения КТ- и МРТ-исследований в онкологии с использованием внутривенного контрастного усиления. Ч. 2. Медицинский алфавит. 2013; 23 (3–4): 29–37.
  17. Abedi S.M., Mardanshahi A., Shahhosseini R., Hosseinimehr S.J. Nuclear medicine for imaging of epithelial ovarian cancer. Future Oncol. 2016; 12 (9): 1165–1177. DOI:10.2217/fon.16.19.
  18. Cai S.Q., Zhao S.H., Qiang J.W., Zhang G.F., Wang X.Z., Wang L. Ovarian Sertoli-Leydig cell tumors: MRI findings and pathological correlation. //J Ovarian Res. 2013; 6 (1):73. DOI: 10.1186/1757–2215–6-73.
  19. Сафонова М.А., Диомидова В.Н. Комплексная лучевая диагностика опухолевого поражения органов малого таза при синхронных полинеоплазиях. Современные тенденции развития науки и технологий. 2015; 6 (4): 88–90.
  20. Bollineni V.R., Kramer G., Liu Y., Melidis C., deSouza N.M. A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer. Cancer Treat Rev. 2015; 41 (6): 496–502.DOI: 10.1016/j.ctrv.2015.03.010

file

download